Azlocillin Sodium

阿洛西林钠

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAzlocillin Sodium
Drug Alias Name氧咪苄青霉素钠叠氮西林钠苯咪唑青霉素AzlinSecuropen +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsUrinary Tract InfectionsSepsisRespiratory Tract Infections +[5] 
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryMainland China
Original Approved Date1996/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang Jinhua Conba Bio-Pharm Co Ltd
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsUrinary Tract InfectionsSepsisRespiratory Tract Infections +[4] 

Other Information

ATC CodeJ01CA09
Related LinksWikipediaDrugBankKEGG